Business Context and Reporting Period
Company: Nano Dimension Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2023 (Report No. 5)
Date of Filing: January 27, 2023
Principal Executive Offices: Ness Ziona, Israel
This filing announces the adoption of a Rights Plan (Poison Pill) by the Board of Directors on January 25, 2023, intended to protect shareholder interests and ensure the Board has sufficient time to evaluate any attempts to control or significantly influence the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance disclosure regarding the adoption of a Rights Plan and does not contain financial performance data.
Material Changes
The primary material change is the implementation of a Rights Plan effective upon the issuance of special purchase rights on February 6, 2023. Key terms include:
- Trigger Threshold: The plan is triggered if any person or group acquires beneficial ownership of 10% or more of the Company's Ordinary Shares (excluding permitted offers).
- Dilution Mechanism: Upon triggering, all holders of Rights except the Acquiring Person may purchase one-half of one (0.5) American Depository Share (ADS) at a purchase price of $0.01 per ADS.
- Grandfathering: Existing holders of 10% or more at the time of the announcement are grandfathered, provided they do not increase their ownership beyond specific thresholds.
- Expiration: The Rights will expire on January 27, 2024.
Guidance, Outlook, and Risks
Management Commentary: The Board believes the Rights Plan is an effective course of action to fulfill fiduciary duties and enable shareholders to realize long-term value. It is designed to encourage potential acquirers to negotiate directly with the Board rather than attempting a hostile takeover.
Risks and Contingencies:
- Substantial Dilution: The plan may cause substantial dilution to any person or group that acquires 10% or more of the outstanding Ordinary Shares.
- Void Rights: Rights held by an Acquiring Person or its affiliates are void and may not be exercised.
- Redemption: The Board may redeem the Rights at no consideration at any time prior to a person becoming an Acquiring Person.
- Amendments: The Board may amend the Rights Agreement without shareholder consent, provided the amendment does not adversely affect holders after an Acquiring Person has emerged.
Investor Verification Checklist
- Verify the exact date of the Rights issuance (February 6, 2023) and the Distribution Record Date.
- Confirm current beneficial ownership percentages of major shareholders to assess if the 10% trigger threshold is currently active or grandfathered.
- Review the full Rights Agreement (Exhibit 4.1) for specific exceptions to the "Acquiring Person" definition.
- Monitor for any Board announcements regarding the redemption of the Rights prior to a triggering event.
- Check for any subsequent filings regarding tender offers or merger transactions that might activate the exchange provisions.